BAP-65 Score Calculator – COPD Exacerbation Mortality Risk

Clinical calculation support · Verify results before clinical use

BAP-65 Risk Assessment

Enter the patient's findings at initial hospital assessment.

—Risk class
B

Blood Urea Nitrogen (BUN)

Elevated BUN is present when the value is greater than 25 mg/dL.

B factor
Enter the measured laboratory value.
Threshold: BUN >25 mg/dL (urea >8.93 mmol/L).
A

Altered Mental Status

Glasgow Coma Scale (GCS) <14, or physician-documented disorientation, stupor, or coma.

A factor
P

Pulse Rate

Tachycardia is defined as pulse rate greater than 109 beats/min.

P factor
65

Age

Age is used to distinguish Class I from Class II only when none of the three BAP factors is present.

Class modifier
The original derivation cohort included patients older than 40 years.
—BAP-65
Risk classification
Enter patient data
Complete all required fields to calculate the risk class.
Clinical interpretation The calculator will classify the patient after all required inputs have been entered.
CriterionEntered findingClassification role
No calculation yet.

BAP-65 is an adjunct to clinical assessment and must not delay respiratory support or escalation when clinically indicated.

About the BAP-65 Score

BAP-65 is a clinical risk classification developed for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). It was designed to stratify in-hospital mortality risk and is also associated with the need for mechanical ventilation.

The original model uses three principal risk factors: blood urea nitrogen (BUN) >25 mg/dL, altered mental status, and pulse >109 beats/min. Age is used to separate the two lowest-risk classes when none of the three principal factors is present.

Original BAP-65 class definitions

ClassDefinitionIn-hospital mortality (derivation / validation)
INo BAP factors; age ≤65 years0.3% / 0.3%
IINo BAP factors; age >65 years0.9% / 1.0%
IIIOne BAP factor2.1% / 2.3%
IVTwo BAP factors6.3% / 6.5%
VAll three BAP factors13.8% / 14.1%

Mortality percentages are observed cohort rates from the original derivation and validation populations, not individualized predictions or guaranteed outcomes.

How the factors are defined

  • BUN: >25 mg/dL. When urea is reported in mmol/L, the corresponding threshold is approximately >8.93 mmol/L.
  • Altered mental status: GCS <14 or physician-documented disorientation, stupor, or coma.
  • Pulse: >109 beats/min.
  • Age: ≤65 versus >65 years, used only if all three principal factors are absent.

Clinical use and limitations

The original development cohort included hospitalized patients older than 40 years with AECOPD. The score should not be extrapolated as a stand-alone decision rule for outpatient disposition, and its performance may vary across healthcare settings and patient populations.

BAP-65 does not replace assessment of respiratory distress, blood gases, oxygenation, acid-base status, hemodynamic instability, comorbidities, or the need for non-invasive or invasive ventilatory support. A low class must not override clinical evidence of severe respiratory failure.

References

Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and Need for Mechanical Ventilation in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Development and Validation of a Simple Risk Score. Arch Intern Med. 2009;169(17):1595–1602. DOI: 10.1001/archinternmed.2009.270.
Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a Novel Risk Score for Severity of Illness in Acute Exacerbations of COPD. Chest. 2011;140(5):1177–1183. DOI: 10.1378/chest.10-3035.
Germini F, Veronese G, Marcucci M, et al. Validation of the BAP-65 score for prediction of in-hospital death or use of mechanical ventilation in patients presenting to the emergency department with an acute exacerbation of COPD: a retrospective multi-center study from the Italian Society of Emergency Medicine (SIMEU). Eur J Intern Med. 2019;61:62–68. DOI: 10.1016/j.ejim.2018.10.018.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2026 Report. Official guideline: GOLD 2026 Report and Pocket Guide.
Clinical disclaimer: This calculator is intended for healthcare professional education and clinical decision support. BAP-65 provides population-level risk stratification and does not establish a diagnosis, determine an individual patient's outcome, or prescribe a treatment. Use clinical judgement and current COPD guidance. Do not delay urgent assessment, oxygen/ventilatory support, or escalation of care while calculating a score.